SCHEMBL25815122

SCHEMBL25815122

COC(=O)COC1COc2ccc(C(C)(C)C)cc2OCC(OCC(=O)O)COc2ccc(C(C)(C)C)cc2OC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
NPSR1 Q6W5P4 1/20 0.42
LMNA P02545 3/20 0.41
MAPT P10636 3/20 0.41
HTT P42858 2/20 0.41
HSP90AA1 P07900 1/20 0.41
RECQL P46063 1/20 0.41
CYP19A1 P11511 1/20 0.40
CYP2C19 P33261 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
FFAR1 O14842 2/20 0.38
PPARG P37231 2/20 0.38
PPARD Q03181 2/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
AIMP2 Q13155 2/20 0.37
CXCR5 P32302 1/20 0.37
APLNR P35414 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22134636 0.93 CYP19A1 (0.44) ALDH1A1LMNAMAPTHTTHSP90AA1
SCHEMBL25815359 0.90 ALDH1A1 (0.41) ALDH1A1NPSR1LMNAMAPTHTT
SCHEMBL22134638 0.87 ALDH1A1 (0.41) ALDH1A1NPSR1LMNAMAPTHTT
SCHEMBL25815119 0.85 FFAR1 (0.39) ALDH1A1NPSR1LMNAMAPTHTT
SCHEMBL22134728 0.83 FFAR1 (0.39) ALDH1A1LMNAMAPTHTTHSP90AA1
SCHEMBL22134640 0.72 MAPT (0.38) ALDH1A1LMNAMAPTHTTMEN1
SCHEMBL25815480 0.70 TRPV1 (0.35) ALDH1A1LMNAMAPTHTTMEN1
SCHEMBL22134659 0.70 CYP19A1 (0.43) ALDH1A1LMNAMAPTHTTHSP90AA1
SCHEMBL25815406 0.70 CYP19A1 (0.38) ALDH1A1LMNAMAPTHTTCYP19A1
SCHEMBL25815443 0.70 CYP19A1 (0.36) ALDH1A1NPSR1LMNAMAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219919-A1 LITHIUM EXTRACTION WITH CROWN ETHERS ORCA HOLDINGS, LLC 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219919-A1 LITHIUM EXTRACTION WITH CROWN ETHERS LCLAT1, LCT, IGF2R ALDH1A1 4352/4885NPSR1 2626/4885LMNA 3133/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.